Clinical Trial Update: Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial of IZN-6D4 Gel for diabetic foot ulcers has completed. Sponsor Izun Pharma Ltd reports the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• IZN-6D4 Gel (IZN-6D4 Gel)

Snippet

Sponsor: Izun Pharma Ltd | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED